Summary
Research into the molecular mechanisms of Facioscapulohumeral muscular dystrophy (FSHD) pathogenesis, specifically focusing on the role of HSATII RNA expression and aggregation, to identify new disease biomarkers and therapeutic targets.
Research into the molecular mechanisms of Facioscapulohumeral muscular dystrophy (FSHD) pathogenesis, specifically focusing on the role of HSATII RNA expression and aggregation, to identify new disease biomarkers and therapeutic targets.